Microvolt QRS Alternans Without Microvolt T-Wave Alternans in Human Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias.

Abstract:

:Background Action potential alternans can induce ventricular tachyarrhythmias and manifest on the surface ECG as T-wave alternans (TWA) and QRS alternans (QRSA). We sought to evaluate microvolt QRSA in cardiomyopathy patients in relation to TWA and ventricular tachyarrhythmia outcomes. Methods and Results Prospectively enrolled cardiomyopathy patients (n=100) with prophylactic defibrillators had 12-lead ECGs recorded during ventricular pacing from 100 to 120 beats/min. QRSA and TWA were quantified in moving 128-beat segments using the spectral method. Segments were categorized as QRSA positive (QRSA+) and/or TWA positive (TWA+) based on ≥2 precordial leads having alternans magnitude >0 and signal:noise >3. Patients were similarly categorized based on having ≥3 consecutive segments with alternans. TWA+ and QRSA+ occurred together in 31% of patients and alone in 18% and 14% of patients, respectively. Although TWA magnitude (1.4±0.4 versus 4.7±1.0 µV, P<0.01) and proportion of TWA+ studies (16% versus 46%, P<0.01) increased with rate, QRSA did not change. QRS duration was longer in QRSA+ than QRSA-negative patients (138±23 versus 113±26 ms, P<0.01). At 3.5 years follow-up, appropriate defibrillator therapy or sustained ventricular tachyarrhythmia was greater in QRSA+ than QRSA-negative patients (30% versus 8%, P=0.02) but similar in TWA+ and TWA-negative patients. Among QRSA+ patients, the event rate was greater in those without TWA (62% versus 21%, P=0.02). Multivariable Cox analysis revealed QRSA+ (hazard ratio [HR], 4.6; 95% CI, 1.5-14; P=0.009) and QRS duration >120 ms (HR, 4.1; 95% CI, 1.3-12; P=0.014) to predict events. Conclusions Microvolt QRSA is novel phenomenon in cardiomyopathy patients that can exist without TWA and is associated with QRS prolongation. QRSA increases the risk of ventricular tachyarrhythmia 4-fold, which merits further study as a risk stratifier.

journal_name

J Am Heart Assoc

authors

Suszko A,Nayyar S,Labos C,Nanthakumar K,Pinter A,Crystal E,Chauhan VS

doi

10.1161/JAHA.119.016461

subject

Has Abstract

pub_date

2020-09-01 00:00:00

pages

e016461

issue

17

issn

2047-9980

journal_volume

9

pub_type

杂志文章
  • Physical Activity and Subsequent Risk of Hospitalization With Peripheral Artery Disease and Critical Limb Ischemia in the ARIC Study.

    abstract::Background Whether physical activity is a determinant of peripheral artery disease (PAD) remains unclear. We therefore assessed the association of physical activity (amount and intensity) with subsequent risk of hospitalization with PAD and its severe form, critical limb ischemia, in the ARIC (Atherosclerosis Risk in ...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.119.013534

    authors: Lu Y,Ballew SH,Kwak L,Selvin E,Kalbaugh CA,Schrack JA,Matsushita K,Szklo M

    更新日期:2019-11-05 00:00:00

  • Low Nasal NO in Congenital Heart Disease With Systemic Right Ventricle and Postcardiac Transplantation.

    abstract:BACKGROUND:NO bioavailability has not been systematically examined in congenital heart disease (CHD). To assess NO in patients with CHD, we measured nasal NO (nNO) generated by the nasal epithelia, given blood NO is difficult to measure (half-life, <2 ms). Given NO's role in hemodynamic regulation and the association o...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.117.007447

    authors: Adams PS,Zahid M,Khalifa O,Feingold B,Lo CW

    更新日期:2017-12-06 00:00:00

  • Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery.

    abstract::Background Laboratory studies demonstrate glucose-insulin-potassium (GIK) as a potent cardioprotective intervention, but clinical trials have yielded mixed results, likely because of varying formulas and timing of GIK treatment and different clinical settings. This study sought to evaluate the effects of modified GIK ...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.119.012376

    authors: Zhao K,Zhang Y,Li J,Cui Q,Zhao R,Chen W,Liu J,Zhao B,Wan Y,Ma XL,Yu S,Yi D,Gao F

    更新日期:2020-03-17 00:00:00

  • Association Between Elevated Pulse Pressure and High Resting Coronary Blood Flow Velocity in Patients With Angiographically Normal Epicardial Coronary Arteries.

    abstract:BACKGROUND:The aim of our study was to evaluate the relationship of pulse pressure (PP), a raw index of arterial stiffness, with noninvasively determined coronary flow reserve (CFR) and its components, in patients with angiographically normal epicardial coronary arteries. METHODS AND RESULTS:The study population inclu...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章,多中心研究

    doi:10.1161/JAHA.117.005710

    authors: Lembo M,Sicari R,Esposito R,Rigo F,Cortigiani L,Lo Iudice F,Picano E,Trimarco B,Galderisi M

    更新日期:2017-06-29 00:00:00

  • Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA.

    abstract::Background Higher fibroblast growth factor-23 ( FGF -23) levels are associated with incident heart failure ( HF ) in MESA (the Multiethnic Study of Atherosclerosis). FGF -23 is also associated with left ventricular hypertrophy. Whether the FGF -23 association with HF is similar for heart failure with reduced ejection ...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章,多中心研究

    doi:10.1161/JAHA.117.008334

    authors: Almahmoud MF,Soliman EZ,Bertoni AG,Kestenbaum B,Katz R,Lima JAC,Ouyang P,Miller PE,Michos ED,Herrington DM

    更新日期:2018-09-18 00:00:00

  • Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.

    abstract:BACKGROUND:Bromocriptine-QR (a quick-release formulation of bromocriptine mesylate), a dopamine D2 receptor agonist, is a US Food and Drug Administrration-approved treatment for type 2 diabetes mellitus (T2DM). A 3070-subject randomized trial demonstrated a significant, 40% reduction in relative risk among bromocriptin...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1161/JAHA.112.002279

    authors: Gaziano JM,Cincotta AH,Vinik A,Blonde L,Bohannon N,Scranton R

    更新日期:2012-10-01 00:00:00

  • Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection Fraction.

    abstract:BACKGROUND:Respiratory muscle weakness contributes to exercise intolerance in patients with heart failure with a preserved ejection fraction (HFpEF)-a condition characterized by multiple comorbidities with few proven treatments. We aimed, therefore, to provide novel insight into the underlying diaphragmatic alterations...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.117.006416

    authors: Bowen TS,Brauer D,Rolim NPL,Bækkerud FH,Kricke A,Ormbostad Berre AM,Fischer T,Linke A,da Silva GJ,Wisloff U,Adams V

    更新日期:2017-10-24 00:00:00

  • Elevated Wall Tension Leads to Reduced miR-133a in the Thoracic Aorta by Exosome Release.

    abstract::Background Reduced miR-133a was previously found to be associated with thoracic aortic ( TA ) dilation, as seen in aneurysm disease. Because wall tension increases with vessel diameter (Law of Laplace), this study tested the hypothesis that elevated tension led to the reduction of miR-133a in the TA . Methods and Resu...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.118.010332

    authors: Akerman AW,Blanding WM,Stroud RE,Nadeau EK,Mukherjee R,Ruddy JM,Zile MR,Ikonomidis JS,Jones JA

    更新日期:2019-01-08 00:00:00

  • Endothelial Cell Cystathionine γ-Lyase Expression Level Modulates Exercise Capacity, Vascular Function, and Myocardial Ischemia Reperfusion Injury.

    abstract::Background Hydrogen sulfide (H2S) is an important endogenous physiological signaling molecule and exerts protective properties in the cardiovascular system. Cystathionine γ-lyase (CSE), 1 of 3 H2S producing enzyme, is predominantly localized in the vascular endothelium. However, the regulation of CSE in vascular endot...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.120.017544

    authors: Xia H,Li Z,Sharp TE 3rd,Polhemus DJ,Carnal J,Moles KH,Tao YX,Elrod J,Pfeilschifter J,Beck KF,Lefer DJ

    更新日期:2020-10-20 00:00:00

  • Energy Drinks: Another Cause of QT Prolongation?

    abstract::See Article Shah et al. ...

    journal_title:Journal of the American Heart Association

    pub_type: 评论,社论

    doi:10.1161/JAHA.119.012833

    authors: Winniford MD

    更新日期:2019-06-04 00:00:00

  • Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta-Analysis of Randomized Trials.

    abstract::Background For patients with ST-segment-elevation myocardial infarction (STEMI) and multivessel coronary artery disease, the optimal treatment of the non-infarct-related artery has been controversial. This up-to-date meta-analysis focusing on individual clinical end points was performed to further evaluate the benefit...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.119.015263

    authors: Ahmad Y,Howard JP,Arnold A,Prasad M,Seligman H,Cook CM,Warisawa T,Shun-Shun M,Ali Z,Parikh MA,Al-Lamee R,Sen S,Francis D,Moses JW,Leon MB,Stone GW,Karmpaliotis D

    更新日期:2020-06-16 00:00:00

  • Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study.

    abstract::Background Antazoline mesylate represents an antihistamine capable of rapid and safe cardioversion of atrial fibrillation, yet evidence concerning its efficacy in comparison to other medications is insufficient. The study aimed to evaluate the success rate and safety of pharmacological cardioversion of atrial fibrilla...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.118.010153

    authors: Wybraniec MT,Wróbel W,Wilkosz K,Wrona K,Bula K,Mizia-Stec K

    更新日期:2018-10-16 00:00:00

  • Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.

    abstract:BACKGROUND:Increased platelet aggregation during antiplatelet therapy may predict cardiovascular events in patients with coronary artery disease. The majority of these patients receive aspirin monotherapy. We aimed to investigate whether high platelet-aggregation levels predict cardiovascular events in stable coronary ...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.117.006050

    authors: Larsen SB,Grove EL,Neergaard-Petersen S,Würtz M,Hvas AM,Kristensen SD

    更新日期:2017-08-05 00:00:00

  • Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled Trials.

    abstract::Background Kidney function decreases during the lifetime, and this decline is a powerful predictor of both kidney and cardiovascular outcomes. Statins lower cardiovascular risk, which may relate to beneficial effects on kidney function. We studied whether atorvastatin influences kidney function decline and assessed th...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章,随机对照试验

    doi:10.1161/JAHA.118.010827

    authors: Vogt L,Bangalore S,Fayyad R,Melamed S,Hovingh GK,DeMicco DA,Waters DD

    更新日期:2019-05-07 00:00:00

  • Phosphatidylinositol 3-Kinase-DNA Methyltransferase 1-miR-1281-Histone Deacetylase 4 Regulatory Axis Mediates Platelet-Derived Growth Factor-Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells.

    abstract:BACKGROUND:Platelet-derived growth factor BB, a potent mitogen of pulmonary artery smooth muscle cells (PASMCs), has been implicated in pulmonary arterial remodeling, which is a key pathogenic feature of pulmonary arterial hypertension. Previous microRNA profiling in platelet-derived growth factor BB-treated PASMCs fou...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.117.007572

    authors: Li Y,Li L,Qian Z,Lin B,Chen J,Luo Y,Qu J,Raj JU,Gou D

    更新日期:2018-03-07 00:00:00

  • Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation.

    abstract::Background Previous studies have reported an association between the timing of menarche and cardiovascular disease ( CVD ). However, emerging studies have not examined the timing of menarche in relation to role of estrogen over a lifetime and major adverse cardiac events ( MACE ). Methods and Results A total of 648 wo...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.119.012406

    authors: Lee JJ,Cook-Wiens G,Johnson BD,Braunstein GD,Berga SL,Stanczyk FZ,Pepine CJ,Bairey Merz CN,Shufelt CL

    更新日期:2019-06-18 00:00:00

  • Phenotypic analysis of arrhythmogenic cardiomyopathy in the Hutterite population: role of electrocardiogram in identifying high-risk desmocollin-2 carriers.

    abstract:BACKGROUND:The p.Gln554X mutation in desmocollin-2 (DSC2) is prevalent in ≈10% of the Hutterite population. While the homozygous mutation causes severe biventricular arrhythmogenic right ventricular cardiomyopathy, the phenotypic features and prognosis of heterozygotes remain incompletely understood. METHODS AND RESUL...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.114.001407

    authors: Wong JA,Duff HJ,Yuen T,Kolman L,Exner DV,Weeks SG,Gerull B

    更新日期:2014-12-11 00:00:00

  • Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry.

    abstract::Background Ticagrelor reduces ischaemic end points in acute coronary syndromes. However, outcomes of ticagrelor versus clopidogrel in real-world patients with acute coronary syndromes treated with percutaneous coronary intervention (PCI) remain unclear. We sought to examine whether treatment with ticagrelor is superio...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.119.015990

    authors: Völz S,Petursson P,Odenstedt J,Ioanes D,Haraldsson I,Angerås O,Dworeck C,Hirlekar G,Myredal A,Albertsson P,Råmunddal T,Redfors B,Omerovic E

    更新日期:2020-07-21 00:00:00

  • Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?

    abstract:BACKGROUND:Acute kidney injury (AKI) following primary percutaneous coronary intervention (pPCI) is frequently interpreted as contrast-induced AKI but may result from other insults. We aimed to determine the causal association of contrast material exposure and the incidence of AKI following pPCI using a control group o...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.117.005715

    authors: Caspi O,Habib M,Cohen Y,Kerner A,Roguin A,Abergel E,Boulos M,Kapeliovich MR,Beyar R,Nikolsky E,Aronson D

    更新日期:2017-06-24 00:00:00

  • Rac1 Modulates Endothelial Function and Platelet Aggregation in Diabetes Mellitus.

    abstract:BACKGROUND:Vascular complications and abnormal platelet function contribute to morbidity and mortality in diabetes mellitus. We hypothesized that the Rho-related GTPase protein, Rac1, can influence both endothelial and platelet function and might represent a potential novel therapeutic target in diabetes mellitus. MET...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.117.007322

    authors: Schiattarella GG,Carrizzo A,Ilardi F,Damato A,Ambrosio M,Madonna M,Trimarco V,Marino M,De Angelis E,Settembrini S,Perrino C,Trimarco B,Esposito G,Vecchione C

    更新日期:2018-04-06 00:00:00

  • Early and Late Effects of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease.

    abstract::Background There are limited data about cardiac resynchronization therapy (CRT) in adult congenital heart disease. We aimed to assess early and late outcomes of CRT among patients with adult congenital heart disease. Methods and Results We retrospectively studied 54 patients with adult congenital heart disease (median...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.119.012744

    authors: Yin Y,Dimopoulos K,Shimada E,Lascelles K,Griffiths S,Wong T,Gatzoulis MA,Babu-Narayan SV,Li W

    更新日期:2019-11-05 00:00:00

  • Galectin-3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients.

    abstract::Background Obesity is a precursor to heart failure with preserved ejection fraction. Biomarkers that identify preclinical metabolic heart disease ( MHD ) in young obese patients would help identify high-risk individuals for heart failure prevention strategies. We assessed the predictive value of GAL3 (galectin-3), FST...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.118.011100

    authors: Gopal DM,Ayalon N,Wang YC,Siwik D,Sverdlov A,Donohue C,Perez A,Downing J,Apovian C,Silva V,Panagia M,Kolachalama V,Ho JE,Liang CS,Gokce N,Colucci WS

    更新日期:2019-04-02 00:00:00

  • Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154 000 Individuals.

    abstract::Background Frailty is associated with higher mortality in individuals at high cardiovascular disease (CVD) risk. We hypothesize that frailty is a more important prognostic factor than CVD risk factors and aim to determine the prognostic value of a cumulative deficit frailty index in patients with or at high risk for C...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.119.014686

    authors: Farooqi MAM,Gerstein H,Yusuf S,Leong DP

    更新日期:2020-02-04 00:00:00

  • Aging of the nitric oxide system: are we as old as our NO?

    abstract:BACKGROUND:Impaired generation and signaling of nitric oxide (NO) contribute substantially to cardiovascular (CV) risk (CVR) associated with hypertension, hyperlipidemia, and diabetes mellitus. In our rapidly aging society, advanced age is, in itself, a consistent and independent CVR factor. Many processes involved in ...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.114.000973

    authors: Sverdlov AL,Ngo DT,Chan WP,Chirkov YY,Horowitz JD

    更新日期:2014-08-18 00:00:00

  • Mobile Health Access and Use Among Individuals With or At Risk for Cardiovascular Disease: 2018 Health Information National Trends Survey (HINTS).

    abstract::Background Mobile health (mHealth) technologies can deliver interventions to prevent and manage cardiovascular disease (CVD), but mHealth uptake among those with or at risk for CVD remains incompletely explored. Therefore, in this group, we assessed the prevalence of mHealth access and usage, and the association betwe...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.119.014390

    authors: Shan R,Ding J,Plante TB,Martin SS

    更新日期:2019-12-17 00:00:00

  • Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement.

    abstract:BACKGROUND:The influence of coronary artery disease (CAD) on clinical and echocardiographic outcomes after transcatheter aortic valve replacement (TAVR) is still controversial. We sought to evaluate the impact of CAD severity as measured by the SYNTAX score (SS) on patients undergoing TAVR. METHODS AND RESULTS:A total...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1161/JAHA.116.005070

    authors: Paradis JM,White JM,Généreux P,Urena M,Doshi D,Nazif T,Hahn R,George I,Khalique O,Harjai K,Lasalle L,Labbé BM,DeLarochellière R,Doyle D,Dumont É,Mohammadi S,Leon MB,Rodés-Cabau J,Kodali S

    更新日期:2017-02-20 00:00:00

  • Anatomic Suitability for Branched Thoracic Endovascular Repair in Patients with Aortic Arch Pathological Features.

    abstract::Background Endovascular repair has become a viable alternative for aortic pathological features, including those located within the aortic arch. We investigated the anatomic suitability for branched thoracic endovascular repair in patients previously treated with conventional open surgery for aortic arch pathological ...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.120.016695

    authors: Smorenburg SPM,Montesano M,Hoogteijling TJ,Truijers M,Symersky P,Jansen EK,Zandbergen HR,Wisselink W,van Schaik TG,Yeung KK

    更新日期:2020-10-20 00:00:00

  • Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans.

    abstract::Background Soluble urokinase plasminogen activator receptor (su PAR ) is a proinflammatory biomarker associated with immune activation and fibrinolysis inhibition. Plasminogen activator inhibitor ( PAI -1) is associated with excessive fibrin accumulation, thrombus formation, and atherosclerosis. The relationship betwe...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.118.009881

    authors: Corban MT,Prasad A,Nesbitt L,Loeffler D,Herrmann J,Lerman LO,Lerman A

    更新日期:2018-08-07 00:00:00

  • ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK - AKT Signaling.

    abstract::Background Cardiac hypertrophy has been recognized as an important independent risk factor for the development of heart failure and increases the risk of cardiac morbidity and mortality. A disintegrin and metalloprotease 23 (ADAM23), a member of ADAM family, is involved in cancer and neuronal differentiation. Although...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.118.008604

    authors: Xiang M,Luo H,Wu J,Ren L,Ding X,Wu C,Chen J,Chen S,Zhang H,Yu L,Zou Y,Xu H,Ye P,Chen M,Xia J

    更新日期:2018-09-18 00:00:00

  • Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial.

    abstract:BACKGROUND:We studied (1) the rates of stroke or systemic embolism and bleeding in patients with atrial fibrillation and peripheral artery disease (PAD) and (2) the efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation with and without PAD. METHODS AND RESULTS:The Apixaban for Reduction ...

    journal_title:Journal of the American Heart Association

    pub_type: 杂志文章

    doi:10.1161/JAHA.116.004699

    authors: Hu PT,Lopes RD,Stevens SR,Wallentin L,Thomas L,Alexander JH,Hanna M,Lewis BS,Verheugt FW,Granger CB,Jones WS

    更新日期:2017-01-17 00:00:00